Position in NVS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,367,693
-$59,296 QoQ
Shares Held
8,727
-6.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#531
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NOVEM GROUP holds $29,241,183 across 10 Drug Manufacturers - General names. NVS ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,016 | $7,198,056 | |
| 2 | AMGN |
Amgen Inc
|
14,901 | $5,395,948 | |
| 3 | AZN |
Astrazeneca PLC
|
24,977 | $4,736,137 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
64,002 | $3,687,793 | |
| 5 | ABBV |
AbbVie Inc.
|
8,784 | $2,210,405 | |
| 6 | JNJ |
Johnson & Johnson
|
7,906 | $2,007,884 | |
| 7 | LLY |
ELI LILLY & Co
|
1,672 | $2,005,446 | |
| 8 | NVS |
Novartis AG
This page
|
8,727 | $1,367,693 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,367,693 | 8,727 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,426,989 | 9,342 | Shares | Defined | 2026-04-13 | |
| 2025-12-31 | $1,368,357 | 9,925 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $1,252,133 | 9,764 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $1,159,394 | 9,581 | Shares | Other | 2025-07-16 | |
| No filing history on record for this holder in this stock. | ||||||